Helio Genomics Appoints Experienced Healthcare Technology Executive John Doyle to its Board of Directors

Board appointment strengthens governance, innovation strategy, and long–term value creation in AI–driven early disease detection. IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Helio Genomics, Inc., an AI-powered TechBio company focused on early cancer detection, today announced the...